IL174561D0 - Drug coating providing high drug loading and methods for providing the same - Google Patents

Drug coating providing high drug loading and methods for providing the same

Info

Publication number
IL174561D0
IL174561D0 IL17456106A IL17456106A IL174561D0 IL 174561 D0 IL174561 D0 IL 174561D0 IL 17456106 A IL17456106 A IL 17456106A IL 17456106 A IL17456106 A IL 17456106A IL 174561 D0 IL174561 D0 IL 174561D0
Authority
IL
Israel
Prior art keywords
providing
methods
same
drug
loading
Prior art date
Application number
IL17456106A
Other versions
IL174561A (en
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US50619503P priority Critical
Priority to PCT/US2004/031592 priority patent/WO2005072079A2/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of IL174561D0 publication Critical patent/IL174561D0/en
Publication of IL174561A publication Critical patent/IL174561A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
IL17456106A 2003-09-26 2006-03-26 Dosage form comprising a core and a coating with high water insoluble drug loading and a coating formulation comprising water insoluble drug IL174561A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US50619503P true 2003-09-26 2003-09-26
PCT/US2004/031592 WO2005072079A2 (en) 2003-09-26 2004-09-23 Drug coating providing high drug loading and methods for providing the same

Publications (2)

Publication Number Publication Date
IL174561D0 true IL174561D0 (en) 2006-08-20
IL174561A IL174561A (en) 2012-02-29

Family

ID=34825863

Family Applications (1)

Application Number Title Priority Date Filing Date
IL17456106A IL174561A (en) 2003-09-26 2006-03-26 Dosage form comprising a core and a coating with high water insoluble drug loading and a coating formulation comprising water insoluble drug

Country Status (15)

Country Link
US (3) US8246986B2 (en)
EP (2) EP1708684A2 (en)
JP (1) JP4919801B2 (en)
KR (1) KR20060092255A (en)
CN (4) CN1897924B (en)
AT (1) AT544447T (en)
AU (1) AU2004314693B2 (en)
CA (1) CA2540308C (en)
ES (1) ES2366721T3 (en)
IL (1) IL174561A (en)
MX (1) MXPA06003450A (en)
NO (1) NO20061840L (en)
NZ (1) NZ546148A (en)
WO (1) WO2005072079A2 (en)
ZA (4) ZA200603304B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
EP1708684A2 (en) 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
US20050089570A1 (en) * 2003-09-26 2005-04-28 Evangeline Cruz Oros push-stick for controlled delivery of active agents
NZ546183A (en) * 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
AU2004275816A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
WO2006117803A2 (en) * 2005-03-14 2006-11-09 Devarajan, Padma, Venkitachalam Transmucosal drug delivery systems
CA2605185A1 (en) 2005-04-06 2006-10-12 Mallinckrodt Inc. Matrix-based pulse release pharmaceutical formulation
US20100172989A1 (en) * 2006-01-21 2010-07-08 Abbott Laboratories Abuse resistant melt extruded formulation having reduced alcohol interaction
US20090317355A1 (en) * 2006-01-21 2009-12-24 Abbott Gmbh & Co. Kg, Abuse resistant melt extruded formulation having reduced alcohol interaction
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
WO2008097511A2 (en) 2007-02-07 2008-08-14 Cook Incorporated Medical device coatings for releasing a therapeutic agent at multiple rates
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
US20090022798A1 (en) * 2007-07-20 2009-01-22 Abbott Gmbh & Co. Kg Formulations of nonopioid and confined opioid analgesics
KR20100055431A (en) * 2007-07-20 2010-05-26 애보트 게엠베하 운트 콤파니 카게 Formulations of nonopioid and confined opioid analgesics
BRPI0818762A2 (en) * 2007-10-16 2015-04-07 Labopharm Inc biocamada composition for release of tramadol and acetaminophen, the use of a composition, and method of treating a mammal in need of analgesia
AU2008338207A1 (en) 2007-12-17 2009-06-25 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
JP2011511782A (en) 2008-02-12 2011-04-14 アボット・ラボラトリーズAbbott Laboratories Extended release hydrocodone acetaminophen and its related methods and applications
US8372432B2 (en) * 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
WO2009114648A1 (en) * 2008-03-11 2009-09-17 Depomed Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US20100068278A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liablity Corporation Of The State Of Delaware Ex vivo modifiable medicament release-associations
US20100069887A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multiple chamber ex vivo adjustable-release final dosage form
US20100068233A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Modifiable dosage form
US20100068254A1 (en) * 2008-09-16 2010-03-18 Mahalaxmi Gita Bangera Modifying a medicament availability state of a final dosage form
US20100068275A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Personalizable dosage form
US20100069821A1 (en) * 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex vivo modifiable medicament release-sites final dosage form
CA2736899C (en) 2008-09-25 2016-08-30 Isp Investments Inc. Smooth, high solids tablet coating composition
ES2509497T3 (en) 2008-12-16 2014-10-17 Paladin Labs Inc. Controlled release formulation to avoid misuse
AU2010211220B2 (en) 2009-02-06 2013-08-01 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
CN101856339A (en) * 2009-04-09 2010-10-13 广州柏赛罗药业有限公司 Controlled release dosage form and preparation method thereof
CN101879146A (en) * 2009-05-08 2010-11-10 广州柏赛罗药业有限公司 Controlled release preparation and preparation method thereof
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
PL399450A1 (en) * 2009-08-31 2013-01-21 Depomed, Inc Remaining in the stomach pharmaceutical compositions for the immediate and prolonged release of acetaminophen
JP5758899B2 (en) * 2009-09-17 2015-08-05 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Pellets coated with a coating containing the active substance
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
CN102160855B (en) * 2011-03-30 2013-01-23 吴家安 Dex-ibuprofen sustained release tablets and preparation method thereof
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
JP6199321B2 (en) * 2012-03-02 2017-09-20 ローズ ファーマシューティカルズ エル.ピー. Unauthorized use resistance of the immediate release formulation
WO2014011830A1 (en) 2012-07-12 2014-01-16 Mallinckrodt Llc Extended release, abuse deterrent pharmaceutical compositions
US20170172950A1 (en) * 2013-11-13 2017-06-22 National Defense Education And Research Foundation New hepatotoxicity-free pharmaceutical composition containing acetaminophen drugs
CN104523644B (en) * 2015-01-27 2017-06-20 江苏联环药业股份有限公司 A rapid dissolution of loratadine tablets and its preparation process

Family Cites Families (187)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3173877A (en) 1957-09-09 1965-03-16 Wyandotte Chemicals Corp Detergent compositions comprising inorganic esters of epoxyhydrocarbon polymers
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (en) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
NL145278B (en) 1966-04-06 1975-03-17 Nebraska State Method for the implementation of a transesterification reaction between a liquid polyhydric alcohol and a hydrophobic ester of a long chain fatty acid.
US3546142A (en) 1967-01-19 1970-12-08 Amicon Corp Polyelectrolyte structures
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US4034756A (en) 1971-01-13 1977-07-12 Alza Corporation Osmotically driven fluid dispenser
US3995631A (en) 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3865108A (en) 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4002173A (en) 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4111201A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4207893A (en) 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4320759A (en) 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4278087A (en) 1980-04-28 1981-07-14 Alza Corporation Device with integrated operations for controlling release of agent
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
IT1170387B (en) 1982-06-07 1987-06-03 Glaxo Group Ltd Heterocyclic compounds, process for preparing them and pharmaceutical compositions containing them
US4519801A (en) 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4578075A (en) 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4576604A (en) 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4663149A (en) 1984-03-21 1987-05-05 Alza Corporation Dispenser comprising inner and outer walls functioning as cooperative unit
GB8414221D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
US4847077A (en) 1984-07-18 1989-07-11 Pennwalt Corporation Controlled release pharmaceutical preparations
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
GB8521350D0 (en) 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4763405A (en) 1986-08-21 1988-08-16 Matsushita Electric Industrial Co., Ltd. Chip-placement machine with test function
US4801461A (en) 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US5200193A (en) 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4806359A (en) 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4946675A (en) 1987-05-27 1990-08-07 Xoma Corporation Hepatic blocking agents
US4892778A (en) 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
US4940465A (en) 1987-05-27 1990-07-10 Felix Theeuwes Dispenser comprising displaceable matrix with solid state properties
US5340590A (en) 1987-06-25 1994-08-23 Alza Corporation Delivery system with bilayer osmotic engine
US5023088A (en) 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4915949A (en) 1987-07-13 1990-04-10 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4968509A (en) 1987-07-27 1990-11-06 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5004613A (en) 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4915954A (en) 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5030456A (en) 1988-11-07 1991-07-09 Alza Corporation Dosage form for treating cardiovascular diseases
US4961932A (en) 1987-10-26 1990-10-09 Alza Corporation Plurality of tiny pills in liquid dosage form
US5019397A (en) 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5160743A (en) 1988-04-28 1992-11-03 Alza Corporation Annealed composition for pharmaceutically acceptable drug
US4931285A (en) 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US5006346A (en) 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5024842A (en) 1988-04-28 1991-06-18 Alza Corporation Annealed coats
SE461549B (en) * 1988-06-13 1990-02-26 Sefors Ab Device in a straalningsdetekteringssystem with a gasurladdningsroer
US5245357A (en) 1988-09-07 1993-09-14 Seiko Epson Corporation Page printer
US4854470A (en) 1988-09-16 1989-08-08 Ireland Russ L Paint brush holder
US4996047A (en) 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
SE8804629A (en) 1988-12-22 1988-12-22
CA2007181C (en) 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US4990535A (en) 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5021053A (en) 1989-07-14 1991-06-04 Alza Corporation Oral osmotic device with hydrogel driving member
US5126142A (en) 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
SE9002206D0 (en) 1990-06-20 1990-06-20 Haessle Ab New compounds
PL165898B1 (en) 1990-06-20 1995-02-28 Astra Ab Method of obtaining novel derivatives of dialkoxy pyridinyl benzimidazole
US5156850A (en) 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5166145A (en) 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
US5417682A (en) 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5190765A (en) 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5252338A (en) 1991-06-27 1993-10-12 Alza Corporation Therapy delayed
GB9121204D0 (en) 1991-10-04 1991-11-20 Euro Celtique Sa Medicament
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5273760A (en) 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5858407A (en) 1992-02-27 1999-01-12 Alza Corporation Method for administering tandospirone
US5512299A (en) 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
US5314697A (en) 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
DE4313726A1 (en) 1993-04-27 1994-11-03 Byk Nederland Bv Solid dosage form
SE9301830D0 (en) 1993-05-28 1993-05-28 Ab Astra New compounds
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
SE9302396D0 (en) 1993-07-09 1993-07-09 Ab Astra A novel compound form
EP0804174A4 (en) 1993-07-21 1998-09-09 Univ Kentucky Res Found A multicompartment hard capsule with control release properties
EP0640341A1 (en) 1993-08-27 1995-03-01 Mitsui Toatsu Chemicals, Incorporated Sustained release pharmaceutical composition and process for producing same
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5478577A (en) 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
ZA9503078B (en) 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE69431533D1 (en) 1994-06-13 2002-11-14 Alza Corp Dosage form for administering of liquid pharmaceutical formulation
US5460826A (en) 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5914131A (en) 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US5633011A (en) 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US6491945B1 (en) 1994-09-16 2002-12-10 Alza Corporation Hydrocodone therapy
US5614578A (en) 1994-10-28 1997-03-25 Alza Corporation Injection-molded dosage form
DE19500644B4 (en) 1995-01-12 2010-09-09 Henkel Ag & Co. Kgaa Spray-dried detergent or a component therefor
US5534263A (en) 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
TW493991B (en) 1995-05-08 2002-07-11 Novartis Ag Pharmaceutical composition for oral administration of active agent having low water solubility and process for preparation of the same
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5780058A (en) 1995-07-21 1998-07-14 Alza Corporation Oral delivery of discrete units
US6132420A (en) 1996-02-02 2000-10-17 Alza Corporation Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
AU2059297A (en) 1996-03-12 1997-10-01 Alza Corporation Composition and dosage form comprising opioid antagonist
US5993858A (en) 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
DE69720055T2 (en) 1996-08-16 2003-09-11 Alza Corp Administration form for the delivery of rising doses of active ingredient
JPH10139659A (en) * 1996-09-10 1998-05-26 Freunt Ind Co Ltd Spherical particle group, its production and spherical particle formulation using the same
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
NZ508567A (en) 1998-06-03 2004-02-27 Alza Corp Methods and devices for providing prolonged drug therapy
US5998478A (en) 1997-01-15 1999-12-07 Platt; Chris E. Timed release tablet comprising naproxen and pseudoephedrine
US5859060A (en) 1997-01-15 1999-01-12 Platt; Chris Timed release tablet comprising naproxen and pseudoepherine
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
EP1107740A4 (en) * 1998-08-25 2002-03-06 Platt Chris Timed release tablet comprising naproxen and pseudoephedrine
BRPI9802144B1 (en) 1997-05-30 2017-03-28 Ezequiel Mayorga Jorge improved multilayer osmotic device
MY125849A (en) 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
US6153678A (en) 1997-10-06 2000-11-28 Alza Corporation Injection-moldable composition and article of manufacture comprising same
SK5972000A3 (en) 1997-11-03 2000-12-11 Janssen Pharmaceutica Nv Compositions of lipid lowering agents
DE69807748T2 (en) 1997-12-22 2003-01-02 Alza Corp Membranes for controlling the flow in devices controlled release
CA2314896C (en) * 1997-12-22 2005-09-13 Euro-Celtique, S.A. A method of preventing abuse of opioid dosage forms
SE9704870D0 (en) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation in
FR2772615B1 (en) 1997-12-23 2002-06-14 Lipha multilayer compresses for instant and prolonged release of active substances
AT260640T (en) 1997-12-29 2004-03-15 Alza Corp Osmotic administration system with pegs retention mechanism
AU1937099A (en) 1997-12-31 1999-07-19 Alza Corporation Osmotic drug delivery monitoring system and method
US6245357B1 (en) 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
EE200000796A (en) 1998-04-27 2002-06-17 Janssen Pharmaceutica N.V. A pellet, its preparation process and the pharmaceutical dosage form, for the preparation of pills, the dosage form, a pharmaceutical packaging kasutaminefarmatseutilise
US6365183B1 (en) 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
US6183466B1 (en) 1998-08-21 2001-02-06 Alza Corporation Dosage form comprising a capsule
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
US20020006438A1 (en) 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
ES2260962T3 (en) 1998-11-02 2006-11-01 Alza Corporation Controlled delivery of antidepressants.
US20010031279A1 (en) 1998-11-02 2001-10-18 Evangeline Cruz Controlled delivery of antidepressants
WO2000025753A2 (en) 1998-11-02 2000-05-11 Alza Corporation Controlled delivery of active agents
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
DE60042352D1 (en) 1999-02-10 2009-07-23 Pfizer Prod Inc contain osmotic system for the administration of active substances, the solid amorphous dispersions
DE19915420A1 (en) * 1999-04-06 2000-10-12 Basf Ag Stabilized polyvinyl preparations
US6174547B1 (en) 1999-07-14 2001-01-16 Alza Corporation Dosage form comprising liquid formulation
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6491683B1 (en) 1999-09-07 2002-12-10 Alza Corporation Osmotic dosage form composed of an extruded polymer tube form
US6387403B1 (en) 1999-09-15 2002-05-14 Alza Corporation Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
DE60019334T2 (en) 1999-12-09 2005-09-08 Alza Corp., Mountain View Antiviral drug
US6613357B2 (en) 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist
US6491949B2 (en) 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6245657B1 (en) 2000-04-03 2001-06-12 Taiwan Semiconductor Manufacturing Company Self-aligned, low contact resistance, via fabrication process
WO2002005647A1 (en) 2000-07-13 2002-01-24 Euro-Celtique, S.A. Salts and bases of 17-(cyclopropylmethyl)-4,5 alpha-epoxy-6-methylenemorphinan-3,14 diol for optimizing dopamine homeostasis during administration of opioid analgesics
JP2004512298A (en) 2000-10-26 2004-04-22 メータ,アテュル エム. How to use delayed and sustained release formulations, and it
JP3895570B2 (en) 2000-12-28 2007-03-22 株式会社ルネサステクノロジ Semiconductor device
AU2002303614B2 (en) 2001-05-02 2005-02-10 Euro-Celtique S.A. Once-a-day oxycodone formulations
AU2002320360B2 (en) 2001-07-10 2005-05-26 Teva Pharmaceutical Industries Ltd. Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
US6605302B2 (en) 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist
GB0117618D0 (en) 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6669955B2 (en) 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
US20030092724A1 (en) * 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
EP1458353A1 (en) 2001-12-19 2004-09-22 ALZA Corporation Formulation dosage form for the controlled delivery of ther apeutic agents
US20030198619A1 (en) 2001-12-19 2003-10-23 Dong Liang C. Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
JP4510467B2 (en) 2002-02-19 2010-07-21 スリーエム イノベイティブ プロパティズ カンパニー Temperature control apparatus and method for high-energy electrochemical cells
DE60323482D1 (en) * 2002-05-06 2008-10-23 Massachusetts Inst Technology Diffusion controlled dosage form and method of preparation printing by means of three-dimensional
PL372797A1 (en) 2002-05-31 2005-08-08 Alza Corporation Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
AR040306A1 (en) 2002-06-28 2005-03-23 Alza Corp Controlled release capsule formulation for the administration of liquid
WO2004010970A1 (en) 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
JP4426449B2 (en) 2002-09-12 2010-03-03 財団法人化学及血清療法研究所 Human anti-human mcp-1 antibodies and antibody fragments
US6893660B2 (en) 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
WO2004056337A2 (en) 2002-12-18 2004-07-08 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
FR2855756B1 (en) * 2003-06-06 2005-08-26 Ethypharm Sa multilayer orodispersible compresses
CN1859897A (en) 2003-07-31 2006-11-08 阿尔扎公司 Permeation-resistant osmotic engine and dosage form for controlled release of a liquid active agent formulation
EP1708684A2 (en) 2003-09-26 2006-10-11 Alza Corporation Drug coating providing high drug loading and methods for providing the same
AU2004275816A1 (en) 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20050089570A1 (en) 2003-09-26 2005-04-28 Evangeline Cruz Oros push-stick for controlled delivery of active agents
US20080031901A1 (en) 2004-09-24 2008-02-07 Abbott Laboratories Sustained release monoeximic formulations of opioid and nonopioid analgesics
NZ546183A (en) 2003-09-26 2011-04-29 Alza Corp Controlled release formulations exhibiting an ascending rate of release
US7457343B2 (en) 2004-11-01 2008-11-25 Avago Technologies Fiber Ip (Singapore) Pte. Ltd. Lens structure, optical transmitter, and method for producing same
MX2008009267A (en) 2006-01-21 2008-10-09 Abbott Gmbh & Co Kg Dosage form and method for the delivery of drugs of abuse.
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods

Also Published As

Publication number Publication date
US20120165361A1 (en) 2012-06-28
EP2184058A1 (en) 2010-05-12
ZA200603309B (en) 2007-09-26
KR20060092255A (en) 2006-08-22
EP1708684A2 (en) 2006-10-11
AU2004314693A1 (en) 2005-08-11
MXPA06003450A (en) 2006-08-31
AU2004314693B2 (en) 2011-04-07
CN101208076B (en) 2011-07-06
US20050112195A1 (en) 2005-05-26
ZA200603301B (en) 2008-11-26
CA2540308C (en) 2013-08-06
ES2366721T3 (en) 2011-10-25
IL174561A (en) 2012-02-29
US8246986B2 (en) 2012-08-21
JP4919801B2 (en) 2012-04-18
ZA200603303B (en) 2007-09-26
CN1897924B (en) 2011-09-21
EP2184058B1 (en) 2012-02-08
CA2540308A1 (en) 2005-08-11
US8226979B2 (en) 2012-07-24
CN1897924A (en) 2007-01-17
NZ546148A (en) 2009-05-31
ZA200603304B (en) 2007-11-28
JP2007506786A (en) 2007-03-22
US20110318392A1 (en) 2011-12-29
NO20061840L (en) 2006-06-26
CN101208076A (en) 2008-06-25
CN1972666A (en) 2007-05-30
WO2005072079A2 (en) 2005-08-11
AT544447T (en) 2012-02-15
CN1917863A (en) 2007-02-21
WO2005072079A3 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
TWI299698B (en) Hard coat film
TWI339912B (en) Aluminum coated with carbon and method for manufacturing the same
DK2298288T4 (en) Uncoated tablet formulation and method
TWI293258B (en) Solution ejecting device and the method forthe same
TWI501690B (en) Display device and method for manufacturing the same
TWI310581B (en) Substrate proximity processing structures and methods for using and making the same
GB2413092B (en) Gaming apparatus and systems
IL168876A (en) Fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
PL362310A1 (en) Polymer powder for the siv process
AU2003297443A1 (en) Delivery systems and methods for gastric reduction
ZA200502434B (en) Agent delivery particle.
EP1833943A4 (en) High-intensity, persistent photoluminescent formulations and objects, and methods for creating the same
HK1084054A1 (en) Microcapsules having multiple shells and method for the preparation thereof
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
AU2003228079A1 (en) Stent coating device
IL164249D0 (en) Acyl-3-carboxphenylurea derivatives, processes forpreparing them and their use
EP1679966A4 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
AU2003247798A1 (en) Nozzles and components thereof and methods for making the same
AU2003263027A8 (en) Methods and systems for storage architectures
IL162548A (en) 4-oxoquinoline derivatives and pharmaceutical compositions containing the same
TWI301147B (en) Adhesive agent, and an optical part using the same
IL170636A (en) Quinazoline derivatives and pharmaceutical compositions containing the same
EP1799154A4 (en) Stent and method for manufacturing the stent
GB0225621D0 (en) Medicament carrier
PL372865A1 (en) Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same

Legal Events

Date Code Title Description
FF Patents granted
MM9K Patent not in force due to non-payment of renewal fees